123
Views
24
CrossRef citations to date
0
Altmetric
Original

Early therapeutic response assessment by 18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure

, , , , , , , , & show all
Pages 596-600 | Received 09 May 2006, Accepted 30 Oct 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sylvain Pilorge, Stephanie Harel, Vincent Ribrag, Frédérique Larousserie, Lise Willems, Patricia Franchi, Marielle Legoff, David Biau, Philippe Anract, Christian Roux, Estelle Blanc-Autran, Richard Delarue, Christian Gisselbrecht, Nicolas Ketterer, Christian Recher, Christophe Bonnet, Frederic Peyrade, Corinne Haioun, Hervé Tilly, Gilles Salles, Pauline Brice, Didier Bouscary, Bénédicte Deau & Jerome Tamburini. (2016) Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies. Leukemia & Lymphoma 57:12, pages 2820-2826.
Read now
Nicolas Aide, Louis Irving & Rodney J. Hicks. (2009) Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier. Leukemia & Lymphoma 50:6, pages 865-867.
Read now
Saar Gill, Rodney J. Hicks & John F. Seymour. (2008) What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?. Leukemia & Lymphoma 49:9, pages 1653-1656.
Read now

Articles from other publishers (20)

Illias Tazi, Amine Benmoussa, Fatima Zahra Boufarissi, RajaaTissir & Fatima Zahara Lahlimi. (2021) Les lymphomes non-Hodgkiniens osseux de l’adulte. Bulletin du Cancer 108:4, pages 424-434.
Crossref
Shengling Ma, Yuanyuan Zhang, Ziying Li, Han Yan, Linghui Xia, Wei Shi & Yu Hu. (2020) Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis. Frontiers in Oncology 10.
Crossref
A.K. Smol’yaninova, E.R. Moskalets, G.A. Yatsyk, I.E. Kostina, A.S. Bogolyubskaya, N.G. Gabeeva, E.G. Gemdzhian, S.A. Tatarnikova, D.S. Badmadzhapova & E.E. Zvonkov. (2020) <sup>18</sup>F-FDG PET and PET-CT as Methods of Diagnosis and Efficacy Estimation of Antitumor Treatment. Clinical oncohematology 13:1, pages 33-49.
Crossref
Thomas W. Georgi, Regine Kluge, Lars Kurch, Lidia Chavdarova, Dirk Hasenclever, Dietrich Stoevesandt, Tanja Pelz, Judith Landman-Parker, W. Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Alexander Fosså, Walentyna Balwierz, Andishe Attarbaschi, Roland A. Ammann, Jane Pears, Andrea Hraskova, Anne Uyttebroeck, Auke Beishuizen, Karin Dieckmann, Thierry Leblanc, Stephen Daw, Julia Baumann, Dieter Körholz, Osama Sabri & Christine Mauz-Körholz. (2018) 18 F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required? . Journal of Nuclear Medicine 59:10, pages 1524-1530.
Crossref
Chelsea C. Pinnix. (2016) Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies. International Journal of Radiation Oncology*Biology*Physics 94:4, pages 641-644.
Crossref
Lode J. Swinnen, Hailun Li, Andrew Quon, Randy Gascoyne, Fangxin Hong, Erik A. Ranheim, Thomas M. Habermann, Brad S. Kahl, Sandra J. Horning & Ranjana H. Advani. (2015) Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404). British Journal of Haematology 170:1, pages 56-65.
Crossref
Carlo Messina, David Christie, Emanuele Zucca, Mary Gospodarowicz & Andrés J.M. Ferreri. (2015) Primary and secondary bone lymphomas. Cancer Treatment Reviews 41:3, pages 235-246.
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Niels MurawskiGerhard HeldMarita ZiepertBarbara KempfAndreas ViardotMathias HänelMathias Witzens-HarigRolf MahlbergChristian Rübe, Jochen Fleckenstein, Carsten ZwickBertram Glass, Norbert Schmitz, Samira ZeynalovaMichael Pfreundschuh. (2014) The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas. Blood 124:5, pages 720-728.
Crossref
Gerhard HeldSamira ZeynalovaNiels MurawskiMarita ZiepertBarbara KempfAndreas ViardotMartin DreylingMichael HallekMathias Witzens-HarigJochen FleckensteinChristian RübeCarsten ZwickBertram GlassNorbert SchmitzMichael Pfreundschuh. (2013) Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement. Journal of Clinical Oncology 31:32, pages 4115-4122.
Crossref
Raghava Kashyap, Eddie Lau, Anupkumar George, John F. Seymour, Stephen Lade, Rodney J. Hicks & Michael S. Hofman. (2013) High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 40:9, pages 1330-1336.
Crossref
John F. Seymour. (2013) X. Extra-nodal lymphoma in rare localisations: bone, breast and testes. Hematological Oncology 31:S1, pages 60-63.
Crossref
Lia M. Halasz, Heather A. Jacene, Paul J. Catalano, Annick D. Van den Abbeele, Ann LaCasce, Peter M. Mauch & Andrea K. Ng. (2012) Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma: Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET. International Journal of Radiation Oncology*Biology*Physics 83:5, pages e647-e654.
Crossref
Yutaka Tsutsumi, Reiki Ogasawara, Fumiyasu Yamamoto, Yutaka Yamada, Yasuyuki Komatsu, Kazuhiko Ichiki, Shinich Ito, Nobuaki Kurauchi, Kazuhiro Kudo, Norihiko Shimoyama, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Hirohito Naruse & Nobuo Masauzi. (2012) Non-Hodgkin’s lymphoma: A case of testis lymphoma metastasized to the gallbladder. Open Journal of Internal Medicine 02:01, pages 11-14.
Crossref
Ranjit Banwait, Kevin O'Regan, Federico Campigotto, Brianna Harris, Dilek Yarar, Meghan Bagshaw, Xavier Leleu, Renee Leduc, Nikhil Ramaiya, Edie Weller & Irene M. Ghobrial. (2011) The role of 18 F‐FDG PET/CT imaging in Waldenstrom macroglobulinemia . American Journal of Hematology 86:7, pages 567-572.
Crossref
V Roland, C Bodet-Milin, A Moreau, T Gastinne, B Mahé, V Dubruille, H Maisonneuve, N Juge-Morineau, P Moreau, H Jardel, L Planche, M Mohty, P Moreau, J-L Harousseau, F Kraeber-Bodéré & S Le Gouill. (2010) Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients. Bone Marrow Transplantation 46:3, pages 393-399.
Crossref
Sonali M. Smith & Julie M. Vose. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 286 307 .
Richard L. Wahl, Heather Jacene, Yvette Kasamon & Martin A. Lodge. (2009) From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors. Journal of Nuclear Medicine 50:Suppl 1, pages 122S-150S.
Crossref
Teruhiko TerasawaJoseph LauStéphane BardetOlivier CouturierTomomitsu HottaMartin HutchingsTakashi NihashiHirokazu Nagai. (2009) Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review. Journal of Clinical Oncology 27:11, pages 1906-1914.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:4, pages 204-211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.